Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29971556 | 1.00 | LOXL2 (0.45) | LOXL2PDPK1 | |
| SCHEMBL20983620 | 0.86 | LOXL2 (0.53) | LOXL2PDPK1 | |
| SCHEMBL28656801 | 0.82 | LOXL2 (0.68) | LOXL2 | |
| SCHEMBL29971060 | 0.82 | LOXL2 (0.68) | LOXL2 | |
| SCHEMBL28644197 | 0.82 | LOXL2 (0.68) | LOXL2 | |
| SCHEMBL29971180 | 0.82 | LOXL2 (0.68) | LOXL2 | |
| SCHEMBL29971266 | 0.81 | LOXL2 (0.69) | LOXL2 | |
| SCHEMBL29970925 | 0.80 | LOXL2 (0.69) | LOXL2 | |
| SCHEMBL29972126 | 0.80 | LOXL2 (0.70) | LOXL2 | |
| SCHEMBL29970984 | 0.80 | PDPK1 (0.40) | PDPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017141049-A1 | METHYLAMINE DERIVATIVES AS LYSYSL OXIDASE INHIBITORS FOR THE TREATMENT OF CANCER | THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (GB) | 2017-08-24 | — | — | WO | disclosed |